Cancer Genetics, Inc. - Product Pipeline Analysis


#157830

37pages

GlobalData

$ 750

In Stock


Cancer Genetics, Inc. (CGI) is the leader in the field of personalized medicine. It offers cancer diagnostics and treatments tailoring the specific genetic profile of the individual. The diagnostic assays and products offered by the company are designed to increase treatment efficacy and reduce healthcare costs of the hematological, urogenital and HPV-associated cancers. The products offered by the company include DNA-FISH Probes, CGH Microarrays and Next-Generation Sequencing. The products under development include FISH Probes for the diagnosis of renal cancer, HPV-associated cancer test and Microarrays for the diagnosis of leukamia, ovarian cancer, cervical cancer, bladder cancer, prostate cancer amongst others. The company also offers comprehensive array of integrated laboratory services for the diagnosis of cancer. CGI is headquartered in New Jersey, the US.

This report is a source for data, analysis and actionable intelligence on the Cancer Genetics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

Key Facts 6
Cancer Genetics, Inc. - Major Products and Services 7
Cancer Genetics, Inc. Pipeline Products by Equipment Type 8
Cancer Genetics, Inc. Pipeline Products by Development Stage 10
Cancer Genetics, Inc. Pipeline Products by Therapy Area 12
FHACT HPV - Associated Cancer Test 14
FHACT HPV - Associated Cancer Test Product Status 14
FHACT HPV - Associated Cancer Test Product Description 14
FReCaD Renal Cancer Test 15
FReCaD Renal Cancer Test Product Status 15
FReCaD Renal Cancer Test Product Description 15
LeukA - Leukemia 16
LeukA - Leukemia Product Status 16
LeukA - Leukemia Product Description 16
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma 17
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma Product Status 17
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma Product Description 17
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma Product Patent Details 17
MatBA Diagnostic Test - Follicular Lymphoma 19
MatBA Diagnostic Test - Follicular Lymphoma Product Status 19
MatBA Diagnostic Test - Follicular Lymphoma Product Description 19
MatBA Diagnostic Test - Follicular Lymphoma Product Patent Details 19
MatBA Diagnostic Test - Mantle Cell Lymphoma 21
MatBA Diagnostic Test - Mantle Cell Lymphoma Product Status 21
MatBA Diagnostic Test - Mantle Cell Lymphoma Product Description 21
MatBA Diagnostic Test - Mantle Cell Lymphoma Product Patent Details 21
MatBA Diagnostic Test - Marginal Zone Lymphoma 23
MatBA Diagnostic Test - Marginal Zone Lymphoma Product Status 23
MatBA Diagnostic Test - Marginal Zone Lymphoma Product Description 23
MatBA Diagnostic Test - Marginal Zone Lymphoma Product Patent Details 23
MatBA Diagnostic Test - Multiple Myeloma 25
MatBA Diagnostic Test - Multiple Myeloma Product Status 25
MatBA Diagnostic Test - Multiple Myeloma Product Description 25
MatBA Diagnostic Test - Multiple Myeloma Product Patent Details 25
UGenRA - Cervix 27
UGenRA - Cervix Product Status 27
UGenRA - Cervix Product Description 27
UGenRA - Endometrium 28
UGenRA - Endometrium Product Status 28
UGenRA - Endometrium Product Description 28
UGenRA - Ovary 29
UGenRA - Ovary Product Status 29
UGenRA - Ovary Product Description 29
UroGenRA - Bladder 30
UroGenRA - Bladder Product Status 30
UroGenRA - Bladder Product Description 30
UroGenRA - Kidney 31
UroGenRA - Kidney Product Status 31
UroGenRA - Kidney Product Description 31
UroGenRA - Prostate 32
UroGenRA - Prostate Product Status 32
UroGenRA - Prostate Product Description 32
Cancer Genetics, Inc. - Key Competitors 33
Cancer Genetics, Inc. - Key Employees 34
Cancer Genetics, Inc. - Locations And Subsidiaries 35
Head Office 35
Recent Developments 36
Cancer Genetics, Inc., Recent Developments 36
Aug 02, 2012: Roche Servicios Selects Cancer Genetics For Diagnosis And Personalization Of Oncology Treatment 36
Mar 23, 2011: Cancer Genetics And Aptiv Solutions Partner To Create More Effective Clinical Trials In Oncology 36

Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

Cancer Genetics, Inc., Key Facts 1
Cancer Genetics, Inc. Key Pipeline Products by Equipment Type 1
Cancer Genetics, Inc. Key Pipeline Products by Therapy Area 1
Cancer Genetics, Inc. Key Pipeline Products by Development Stage 1
Cancer Genetics, Inc., Key Facts 6
Cancer Genetics, Inc., Major Products and Services 7
Cancer Genetics, Inc. Number of Pipeline Products by Equipment Type 8
Cancer Genetics, Inc. Pipeline Products by Equipment Type 9
Cancer Genetics, Inc. Number of Pipeline Products by Development Stage 10
Cancer Genetics, Inc. Pipeline Products by Development Stage 11
Cancer Genetics, Inc. Number of Pipeline Products by Therapy Area 12
Cancer Genetics, Inc. Pipeline Products by Therapy Area 13
FHACT HPV - Associated Cancer Test - Product Status 14
FHACT HPV - Associated Cancer Test - Product Description 14
FReCaD Renal Cancer Test - Product Status 15
FReCaD Renal Cancer Test - Product Description 15
LeukA - Leukemia - Product Status 16
LeukA - Leukemia - Product Description 16
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma - Product Status 17
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma - Product Description 17
MatBA Diagnostic Test - Diffuse Large B-cell Lymphoma - Patent Details1 17
MatBA Diagnostic Test - Follicular Lymphoma - Product Status 19
MatBA Diagnostic Test - Follicular Lymphoma - Product Description 19
MatBA Diagnostic Test - Follicular Lymphoma - Patent Details1 19
MatBA Diagnostic Test - Mantle Cell Lymphoma - Product Status 21
MatBA Diagnostic Test - Mantle Cell Lymphoma - Product Description 21
MatBA Diagnostic Test - Mantle Cell Lymphoma - Patent Details1 21
MatBA Diagnostic Test - Marginal Zone Lymphoma - Product Status 23
MatBA Diagnostic Test - Marginal Zone Lymphoma - Product Description 23
MatBA Diagnostic Test - Marginal Zone Lymphoma - Patent Details1 23
MatBA Diagnostic Test - Multiple Myeloma - Product Status 25
MatBA Diagnostic Test - Multiple Myeloma - Product Description 25
MatBA Diagnostic Test - Multiple Myeloma - Patent Details1 25
UGenRA - Cervix - Product Status 27
UGenRA - Cervix - Product Description 27
UGenRA - Endometrium - Product Status 28
UGenRA - Endometrium - Product Description 28
UGenRA - Ovary - Product Status 29
UGenRA - Ovary - Product Description 29
UroGenRA - Bladder - Product Status 30
UroGenRA - Bladder - Product Description 30
UroGenRA - Kidney - Product Status 31
UroGenRA - Kidney - Product Description 31
UroGenRA - Prostate - Product Status 32
UroGenRA - Prostate - Product Description 32
Cancer Genetics, Inc., Key Employees 34
Cancer Genetics, Inc. Pipeline Products by Equipment Type 8
Cancer Genetics, Inc. Pipeline Products by Development Stage 10
Cancer Genetics, Inc. Pipeline Products by Therapy Area 12